Internal Medicine, Pulmonary Disease · Appleton, WI
NPI
1073672390
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2500 E Capitol Dr, Suite 1700
Appleton, WI, 54911
Phone (920) 734-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,460 services
Medicare patients, 2024
386
Average age 73
Drug cost, 2024
$2.0M
3,129 prescriptions
Company payments, 2025
$449
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott C Parrish was code 99214 (office e&m - established), 180 times for 136 patients. In total Scott C Parrish billed 1,460 services in 41 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 180 | 136 | $88.52 | $16K |
| 94010 Pulmonary Function Testing | Office | 150 | 142 | $18.10 | $2,714 |
| 94729 Pulmonary Function Testing | Office | 147 | 143 | $38.33 | $5,635 |
| 88738 General Laboratory | Office | 102 | 100 | $4.87 | $497 |
| 94729 Pulmonary Function Testing | Facility | 94 | 94 | $5.70 | $536 |
| 94060 Pulmonary Function Testing | Facility | 85 | 85 | $6.87 | $584 |
| 94726 Pulmonary Function Testing | Facility | 79 | 79 | $7.63 | $603 |
| 99204 Office E&M - New | Office | 77 | 77 | $109.42 | $8,425 |
| 99213 Office E&M - Established | Office | 65 | 60 | $59.35 | $3,858 |
| 94060 Pulmonary Function Testing | Office | 61 | 60 | $27.22 | $1,660 |
| 94726 Pulmonary Function Testing | Office | 60 | 60 | $39.60 | $2,376 |
| 95012 Pulmonary | Office | 57 | 56 | $12.98 | $740 |
| 99457 E&M - Miscellaneous | Office | 32 | 18 | $36.75 | $1,176 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 31 | 19 | $46.28 | $1,435 |
| 99454 E&M - Miscellaneous | Office | 16 | 13 | $35.30 | $565 |
By year: 2022 $63K for 1,995 services; 2023 $64K for 1,500 services; 2024 $59K for 1,460 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88738 General Laboratory | 102 | 100 | $4.87 | $497 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott C Parrish prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 761 prescriptions and refills. In total Scott C Parrish wrote 3,129 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 761 | 977 | 144 | $618K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 409 | 504 | 148 | $13K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 385 | 517 | 83 | $243K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 263 | 416 | 70 | $49K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 247 | 315 | 45 | $142K |
| Spiriva Respimat Tiotropium Bromide | 195 | 267 | 42 | $136K |
| Prednisone Generic | 121 | 150 | 50 | $542 |
| Breo Ellipta Fluticasone/Vilanterol | 82 | 138 | 23 | $53K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 81 | 147 | 27 | $13K |
| Symbicort Budesonide/Formoterol Fumarate | 65 | 117 | 18 | $26K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 51 | 51 | 15 | $32K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 46 | 55 | 15 | $8,903 |
| Roflumilast Generic | 40 | 70 | Under 11 | $2,964 |
| Ofev Nintedanib Esylate | 38 | 38 | Under 11 | $516K |
| Advair Diskus Fluticasone Propion/Salmeterol | 33 | 33 | Under 11 | $6,235 |
Brand drugs: 2,490 claims; generic drugs: 639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott C Parrish $449 ($449 in general payments such as food, travel and fees) from 10 companies. The largest payer was Galvanize Therapeutics, Inc with $105.
| Company | Payments | Amount |
|---|---|---|
| Galvanize Therapeutics, Inc | 2 | $105 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $84.99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57.43 |
| Verona Pharma, Inc. VRNA | 2 | $52.65 |
| Inspire Medical Systems, Inc. INSP | 1 | $36.8 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.75 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $24.92 |
| Pinnacle Biologics, Inc | 1 | $22.37 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $22.14 |
| Insmed, Inc. INSM | 1 | $13.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.